Public health experts Dr. John Q. Wong (EpiMetrics) and Dr. Anthony Calibo (Jhpiego HAPPI Project) share evidence and strategies on positioning HPV vaccination as a cornerstone of cervical cancer prevention and Universal Health Care during the Philippine Society of Public Health Physicians 7th Annual National Convention (PHCON 2025) with the theme “Hibla at Habi: Weaving a Responsive Health System.”

Public Health Physicians call for Strengthening HPV Vaccination for Cervical Cancer Prevention


Public health physicians continue to champion the cause of human papillomavirus (HPV) vaccination as a critical step in preventing cervical cancer and realizing the goals of Universal Health Care (UHC) in the Philippines.

At the recent Philippine Society of Public Health Physicians 7th Annual National Convention (PHCON 2025) with the theme “Hibla at Habi: Weaving a Responsive Health System,” experts underscored that cervical cancer, a preventable cancer, remains one of the country’s most urgent health challenges, claiming about 12 Filipinas’ lives each day.

They stressed that HPV vaccination, combined with screening and awareness programs, offers a proven and cost-effective way to curb this toll and move closer to eliminating cervical cancer as a public health burden.

HPV Vaccination as a Strategic Investment

Dr. John Q. Wong, renowned epidemiologist, and co-founder and president of EpiMetrics, highlighted the economic and equity benefits of making HPV vaccination a national priority. He said that “for every dollar [peso] you invest in the vaccination program, you get back up to 4x in benefits. Meanwhile, the cost of treatment, depending on the stage, can range between Php 200,000 to Php 1 million.”

Dr. Wong added that prevention saves families from catastrophic health expenses and strengthens the broader health system. “It’s more expensive to buy an iPhone than to invest in protecting our girls through HPV vaccination,” Dr. Wong noted, underscoring that the government will just have to spend less than Php 2,000 per person to provide decades of protection against cervical cancer through the national HPV vaccination program.

He clarified that this figure refers to the program cost shouldered by the government, not the out-of-pocket price of the vaccine. “If we consider the long-term protection against cancer, the HPV vaccine is not a costly investment but rather one of the most cost-effective public health measures available,” he emphasized.

The Role of Physicians and Communities

Drawing from the findings of the HAPPI Project, Dr. Anthony Calibo, Technical Advisor of Jhpiego’s HPV Vaccination Learning Project (HPV Vaccination Acceleration Program Partners Initiative), noted that HPV vaccine coverage rates (VCR) remain low across many areas, largely because the current Department of Health (DOH) allocation of vaccines is insufficient to meet the demand. “This is why physicians must step up and help bridge the gap,” he stressed. “Doctors should influence mayors, governors, and councilors to prioritize HPV vaccination.”

He also pointed to best practices from HAPPI, which showed that integrating HPV vaccination into school-based immunization drives and adolescent health check-ups boosts uptake. “Teachers play a critical role. When consent forms are sent home, parents often go back to teachers with questions. Equipping them to communicate the benefits of the vaccine is essential to building trust.”

Adding to Dr. Calibo’s sharing, Dr. Wong urged reframing the message: “It’s better to present HPV immunization as a cancer prevention vaccine. Who doesn’t want to prevent cancer? This is one of only two vaccines in the world that can actually do that.”

Local Leadership: Banna, Ilocos Norte Sets the Standard

The municipality of Banna, Ilocos Norte, led by mayor-physician Hon. Dr. Chrislyn Abadilla, has become a model for local government action. The current Department of Health (DOH) HPV Vaccination Program using the quadrivalent HPV Vaccine caters only to a small percentage of Grade 4 female students. But by early 2024, the town achieved 90% HPV vaccination coverage among girls aged 9-14, making it the first in the country to meet the World Health Organization’s elimination target.

In August 2025, Banna’s program expanded to include young women up to age 26 and female healthcare workers, all funded by the local government. This is to ensure that females who missed or were not covered by the DOH HPV vaccination program in previous years would have a chance to get the HPV Vaccination for free from their LGU. The quadrivalent HPV vaccine also protects against genital warts, making it a valuable part of adolescent sexual and reproductive health programs.

“What was once thought impossible for a small municipality is now being celebrated as a model of courage, compassion, and commitment to public health,” Dr. Abadilla shared in a video message.

Toward Universal Health Care

Dr. Wong and Dr. Calibo agreed that scaling up HPV vaccination requires both political will and community partnership. They urged national and local governments to secure budgets, integrate vaccination into existing programs, and train educators and health workers to dispel myths.

“With the right investment and physician leadership, HPV vaccination can protect our daughters, empower our communities, and bring us closer to eliminating cervical cancer.”

To get the latest update, follow me on my social media accounts.